John Caloz
Financieel Directeur/CFO bij LADRX CORPORATION
Vermogen: 19 $ op 31-05-2024
Profiel
John Y.
Caloz is currently the Chief Financial Officer, Treasurer & Senior VP at LadRx Corp.
He previously held positions as the Chief Financial Officer at Iris International, Inc. from 2001 to 2004, the Chief Financial Officer & Senior VP-Finance at Phoenix International Life Sciences, Inc. from 1993 to 1999, the Chief Financial Officer & Treasurer at TearLab Corporation, Inc. from 2005 to 2007, and the Chief Financial Officer at Synexus Compass, Inc. from 1998 to 1999.
Prior to these roles, he was a Partner at Rooney, Greig, Whitrod, Filion & Associates of Saint Laurent from 1983 to 1993.
Mr. Caloz completed his undergraduate degree at York University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LADRX CORPORATION
0.00% | 27-03-2024 | 7 ( 0.00% ) | 19 $ | 31-05-2024 |
Actieve functies van John Caloz
| Bedrijven | Functie | Begin |
|---|---|---|
| LADRX CORPORATION | Financieel Directeur/CFO | 01-01-2009 |
Eerdere bekende functies van John Caloz
| Bedrijven | Functie | Einde |
|---|---|---|
| TEARLAB CORPORATION | Financieel Directeur/CFO | 01-01-2007 |
Iris International, Inc.
 Iris International, Inc. Medical SpecialtiesHealth Technology IRIS International, Inc. engages in the manufacture of surgical and medical instruments. Its products include in vitro diagnostic systems. The company was founded in 1979 and is headquartered in Brea, CA. | Financieel Directeur/CFO | 01-01-2004 |
Synexus Compass, Inc.
 Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA. | Financieel Directeur/CFO | 01-01-1999 |
Phoenix International Life Sciences, Inc.
 Phoenix International Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sotera Health Co., Phoenix International Life Sciences, Inc. is a Canadian company that provides bioanalytical research and clinical testing services. The company is based in Saint-Laurent, Canada. Phoenix International Life Sciences was acquired by Nordion (Canada), Inc., part of Sotera Health Co. from July 30, 2018 on May 22, 2000 for $236.74 million. | Financieel Directeur/CFO | 01-01-1999 |
| Rooney, Greig, Whitrod, Filion & Associates of Saint Laurent | Corporate Officer/Principal | 01-01-1993 |
Opleiding van John Caloz
| York University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LADRX CORPORATION | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Iris International, Inc.
Iris International, Inc. Medical SpecialtiesHealth Technology IRIS International, Inc. engages in the manufacture of surgical and medical instruments. Its products include in vitro diagnostic systems. The company was founded in 1979 and is headquartered in Brea, CA. | Health Technology |
Phoenix International Life Sciences, Inc.
Phoenix International Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sotera Health Co., Phoenix International Life Sciences, Inc. is a Canadian company that provides bioanalytical research and clinical testing services. The company is based in Saint-Laurent, Canada. Phoenix International Life Sciences was acquired by Nordion (Canada), Inc., part of Sotera Health Co. from July 30, 2018 on May 22, 2000 for $236.74 million. | Commercial Services |
TearLab Corporation, Inc.
 TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Southlake, TX. | Health Technology |
Synexus Compass, Inc.
Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA. | Health Services |
| Rooney, Greig, Whitrod, Filion & Associates of Saint Laurent |
